Table 1 Clinical characteristics for the 780 individuals in the Lifestyle, Biomarkers and Atherosclerosis (LBA) cohort
Women (n = 532) | Men (n = 248) | p | |
|---|---|---|---|
Age (years) | 21.9 ± 1.9 | 22.0 ± 2.0 | 0.193 |
Height (cm) | 168.6 ± 6.4 | 181.7 ± 6.6 | < 0.001 |
Weight (kg) | 63.6 ± 10.9 | 77.6 ± 11.4 | < 0.001 |
BMI (kg/m2) | 22.3 ± 3.4 | 23.5 ± 3.0 | < 0.001 |
Systolic blood pressure (mmHg) | 109.8 ± 8.4 | 122.2 ± 10.9 | < 0.001 |
Diastolic blood pressure (mmHg) | 63.9 ± 6.3 | 64.2 ± 6.7 | 0.003 |
Carotid intima-media thickness (mm) | 0.49 ± 0.057 | 0.50 ± 0.064 | 0.028 |
CRP median (Q1–Q3) (mg/L) | 0.69 (0.34–1.76) | 0.55 (0.24–1.16) | < 0.001 |
Insulin, fasting (mU/L) median (Q1–Q3) | 7.11 (5.14–9.79) | 6.97 (4.72–9.08) | 0.213 |
Glucose, fasting (mmol/L) | 4.93 ± 0.34 | 5.17 ± 0.33 | < 0.001 |
Triglycerides (mmol/L) Median (Q1–Q3) | 0.70 (0.60–1.00) | 0.70 (0.60–0.90) | 0.956 |
HDL (mmol/L) | 1.45 ± 0.36 | 1.23 ± 0.28 | < 0.001 |
LDL (mmol/L) | 2.30 ± 0.72 | 2.31 ± 0.69 | 0.974 |
Total cholesterol (mmol/L) | 4.30 ± 0.77 | 4.06 ± 0.79 | < 0.001 |
Estrogen contraceptive user (No/yes) | 399/133 | 248/0 |